Assign newsletters to this category

Stock World Weekly: All Clear Overhead?

Screen Shot 2014-08-30 at 11.13.45 PM

Here’s the latest issue of Stock World Weekly: 9-1-2014 SWW PDF.

Click on this link and take a free trial to the weekly newsletter. 

Note: I have recently brought up the issue of whether selling puts is [Continue Reading]

Quest to Diagnose Obamacare Beneficiaries

DGXValueLinemetrics (1)

Quest to Diagnose Obamacare Beneficiaries

By Ilene with Paul Price

Dr. Paul Price expects the 2014 implementation of Obamacare to provide a major stimulus for physicians to order more lab tests, as at least 30 million currently uninsured people gain coverage. While [Continue Reading]

Selling Puts (part 2)

Selling Puts on Value Companies

By Paul Price

Review and two more selling put ideas (see part 1 here). Updated Virtual Portfolios here. From Bet with the House, Market Shadows Newsletter, 1/15

Options [Continue Reading]

Silver Lining Play on Tiffany’s Plunge

Screen Shot 2013-01-14 at 1.41.00 AM

Silver Lining Play on Tiffany’s Plunge 

Courtesy of Paul Price

High-end retailer Tiffany (TIF, $60.28) has posted excellent long-term results. Tiffany’s took a hit last Thursday after lowering guidance to $3.20 per share for the fiscal year ending Jan. 31, 2013.  This will be just its [Continue Reading]

Bet with the House

Bet with the House

Event Horizons ~ presented in Market Shadows Newsletter, Bet with the House, Jan. 14, 13

Tax selling in December turned into mutual fund funding in January. A reversal of money flows – not the reason to be bullish. However, we’re still on the bullish theme because the Fed is [Continue Reading]

Selling Puts on Value Companies

ESRX and KSS option prices (1)

Selling Puts on Value Companies – A New Market Shadows Virtual Portfolio

(Also presented in Market Shadows Newsletter, Bet with the House, Jan. 14, 13)

By Ilene with Paul Price

Options are not just for speculation. One excellent use of options involves selling puts on stocks you’d like to own, but at [Continue Reading]

Virtual Value Portfolio (1/4/13)

Snapshots of Paul’s Market Shadows Virtual Value Portfolio (1/4) and the Dividend Table of 2012.

Paul Price is not currently writing covered calls on these positions, as noted in Covered Calls – The Hidden Risk for [Continue Reading]

Closing the Virtual Options Portfolio of 2012

Year end summary and closing of Pharmboy’s Virtual Options Portfolio.

It is time to review and close positions in the Virtual Options Portfolio. Many of the virtual portfolio’s option positions are set to expire in January. Here are some of the positions Pharmboy is closing:

BMY (100 shares) [Continue Reading]

Updated Paul’s Virtual Value Portfolio (12/31/12)

Snapshots of Paul’s Market Shadows Virtual Value Portfolio and the Dividend Table of 2012.

Paul Price is not currently writing covered calls on these positions, as noted in Covered Calls – The Hidden Risk for 2013 and [Continue Reading]

Three Retail Bargains – Not Damaged Goods

Three Retail Bargains – Not Damaged Goods

Courtesy of Paul Price

Off-price retailers often sell last season’s merchandise, ‘scratch and dent’ or otherwise less than perfect wares. Shoppers are still willing to buy at the right price. The stock market is the same way. It’s rare [Continue Reading]

Comfortably Bullish

The New Year’s edition of Market Shadows newsletter is now available: MarketShadows, “Comfortably Bullish,” January 4 2013.

 

Comfortably Bullish

 

Glimpse into the Future section of the MarketShadows Newsletter, January 4 2013

By Ilene

We are starting 2013 long stocks in Paul’s Virtual Value Portfolio with no covered call writing [Continue Reading]

Comfortably Bullish

The New Year’s edition of Market Shadows newsletter is now available: MarketShadows, Comfortably Bullish, January 3.

Comfortably Bullish

Glimpse into the Future section of Market Shadow’s Newsletter

By Ilene

We are starting 2013 long stocks in Paul’s Virtual Value Portfolio with no covered call writing hedges for one reason – the Federal Reserve’s [Continue Reading]

Virtual Value Portfolio Follow-Up

MAB83611

 

Virtual Value Portfolio Follow-Up

 

By Paul Price of Market Shadows

Profits have been building and dividends accumulating since we started this up in late October with a virtual $100,000 in cash. We’ve already booked more than $1,100 in cash distributions (including some special year-end payments, see chart below).

We added two new stocks [Continue Reading]

Market Shadows Newsletter: Lights, Camera, Rally?

Lights, Camera, Rally?

In this week’s Market Shadows Newsletter: Lights, Camera, Rally?, Paul Price explores Price/Earnings (P/E) ratios and finds the S&P 500 trading at average levels. This, however, is not the end of the story. P/Es do not exist [Continue Reading]

P/E 10 as a Valuation Gauge = Incomplete Information

From Market Shadows Newsletter: Lights, Camera, Rally? (9/17)

To assess whether stocks are cheap or expensive, we explored P/Es and decided that overall, the S&P is trading at about average levels. However, the playing field shifts with interest rates. Right now, interest rates are being artificially held down by the quantitative easing [Continue Reading]

Special Dividends & Virtual Value Portfolio

Special Dividends & Virtual Value Portfolio 

From Market Shadows Newsletter: Lights, Camera, Rally? (12/17): Virtual Value Portfolio Update

Two stocks in Paul Price’s Virtual Value Portfolio - Interactive Brokerage Group (IBKR) and Dolby (DLB) – are going ex dividend for special payments this week on Wed. 12/19.

Note from [Continue Reading]

MMM: Post-Its and Magic Tape Could Stick the Landing

MMM: Post-Its and Magic Tape Could Stick the Landing

Courtesy of Dr. Paul Price

From Market Shadows Newsletter: Lights, Camera, Rally?  (12/17)

It’s hard to go wrong over the long-term with shares of a high-quality, predictable growth stock. That’s especially true when it sports an A++ balance sheet and provides [Continue Reading]

Monoclonal Antibodies Companies (Part 2)

Monoclonal Antibodies (Part 2)

Courtesy of 

From the Market Shadows Newsletter: Lights, Camera, Rally? (12/17)

In Part 1 of Monoclonal Antibody Companies, I highlighted a leader in the field, Seattle Genetics (SGEN). It’s technology incorporates monoclonal [Continue Reading]

China Breaks Higher

China (Stock Market) Breaks Higher

From Market Shadows Newsletter: Lights, Camera, Rally? (12/17)

Chart Art by Richard Chappell (Springheel Jack)

We have a trend-less market at the moment – a stock picker’s market. But I’m still leaning bullish into 2013. On US equities, the P/E ratios are reasonable by historical standards [Continue Reading]

Is the Stock Market Cheap?

Is the Stock Market Cheap?

Adapted from Is the Stock Market Cheap by Doug Short

Here is a new update of a popular market valuation method using the [Continue Reading]

Tables Can Turn ~ Market Shadows Newsletter (12/9)

Tables Can Turn

The latest Market Shadows Newsletter: Tables Can Turn, features Lee Adler, Dr. Paul Price and Richard Chappell.

Sections include:

Event Horizons: Jobs Data on Trend ~ By Lee Adler of the Wall Street [Continue Reading]

Unloved Stocks Rocked in 2012

Unloved Stocks Rocked in 2012

By Dr. Paul Price

Most analysts look for the same set of characteristics when designating companies with ‘buy’ labels. Typically they want to see earnings growth and positive share price momentum before they are willing to recommend purchase. The requirement that shares exhibit technical strength ensures that they can [Continue Reading]

There is No Spoon

There is No Spoon

Courtesy of Rich Chappell (Springheel Jack)

Is the value of gold purely notional? Does it have value in absolute terms? Does our currency? Does anything? If value is what someone will pay for something, then we still have to figure out the value of that store of value – [Continue Reading]

Event Horizons: Jobs Data on Trend

Truth is needed for informed investment decisions. That has been difficult to find these days. There are so many opinions, so many contradictions, so much misinformation, and so many with a hidden agenda that we will never know. The internet may have provided us with a great means to find truth, but it also increased [Continue Reading]